RE: Revenue21 May 2021 14:09
I agree, I think if you look at the events, the involvement with Edison to have a an opportunity to fund the cash runway. This will be played off against partners in licensing discussions to try and gain commercial traction. With both of those avenues boosting SARs hand in any TO discussion. Layer on top of this the Agile opportunity and I see SAR as holding a strong hand in any discussions. I truly believe that there will be news that will create a step change in the SP which could drop at anytime. IMO a pharma deal may well drop before the Agile news as commercially SAR will be significantly enhanced if a successful candidate.